Boston / November 9–11 — The 11th Microbiome Movement USA Summit will be held at The Colonnade Hotel. The agenda focuses on translating microbiome science into clinically validated therapies, with participants including Ferring Pharmaceuticals, Nestlé Health Science, Vedanta Biosciences, and the Gates Foundation. Sessions address clinical efficacy demonstration, investor confidence rebuilding, and regulatory pathways .
Houston / November 10 — The 15th Annual Texas Life Science Forum takes place at McNair Hall, Rice University. Arthur Sands, President and CEO of Nurix Therapeutics, delivers the keynote. Programming covers biotech capital-raising conditions, AI in healthcare innovation, FDA priorities, and academic-to-commercial translation. Selected ventures present to investors throughout the day .
San Francisco Bay Area / November 9 — A one-day workshop on QT prolongation assessment in preclinical and clinical development will be held in the Mid-Peninsula area. Speakers include representatives from Charles River Laboratories, Aligos Therapeutics, Clario, and the FDA. The program addresses ICH S7B/E14 strategies and thorough QT study waivers .
San Francisco / November 12–13 — The UCSF and California Northstate University symposium „Advancing Precision Pharmacology for Maternal and Child Health“ convenes at the Wayne and Gladys Valley Center for Vision. The forum targets evidence gaps in pharmacotherapy for pregnant women, fetuses, and children .
Notable events outside the window: The ASTCT Gene Therapy Summit concluded November 4–5 in Boston . The 4th LNP Characterization and Analytical Development Summit is scheduled for November 18–19 in Boston . The Personalized Medicine Conference runs November 18–19 in Boston/Cambridge . No verifiable major national life sciences events were identified for November 11 and 13–15 beyond those noted above.
